Alto Neuroscience, Inc. (NYSE: ANRO) reported Q3 EPS of ($0.52), $0.12 better than the analyst estimate of ($0.64).

For earnings history and earnings-related data on Alto Neuroscience, Inc. (ANRO) click here.